Jeff Fairman Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Jeff Fairman.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Jeff Fairman. Jeff Fairman is VP, Research in Vaxcyte, Inc. ($PCVX).
Latest Insider Trading Transactions of Jeff Fairman
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 23 2021 | PCVX | Vaxcyte, Inc. | Fairman Jeff | VP, Research | Option Exercise | M | 1.79 | 2,793 | 4,999 | 88,836 | |
| Apr 23 2021 | PCVX | Vaxcyte, Inc. | Fairman Jeff | VP, Research | Buy | M | 1.79 | 2,793 | 4,999 | 4,201 | 1.4 K to 4.2 K (+198.37 %) |
| Apr 06 2021 | PCVX | Vaxcyte, Inc. | Fairman Jeff | VP, Research | Option Exercise | A | 20.93 | 40,000 | 837,200 | 40,000 | |
| Mar 29 2021 | PCVX | Vaxcyte, Inc. | Fairman Jeff | VP, Research | Option Exercise | M | 0.04 | 4,750 | 190 | 7,259 | |
| Mar 29 2021 | PCVX | Vaxcyte, Inc. | Fairman Jeff | VP, Research | Sell | S | 24.48 | 1,361 | 33,317 | 1,408 | 2.8 K to 1.4 K (-49.15 %) |
| Mar 29 2021 | PCVX | Vaxcyte, Inc. | Fairman Jeff | VP, Research | Sell | S | 23.64 | 3,389 | 80,116 | 2,769 | 6.2 K to 2.8 K (-55.03 %) |
| Mar 29 2021 | PCVX | Vaxcyte, Inc. | Fairman Jeff | VP, Research | Buy | M | 0.04 | 4,750 | 190 | 6,158 | 1.4 K to 6.2 K (+337.36 %) |
| Mar 02 2021 | PCVX | Vaxcyte, Inc. | Fairman Jeff | VP, Research | Option Exercise | M | 0.04 | 4,750 | 190 | 12,009 | |
| Mar 02 2021 | PCVX | Vaxcyte, Inc. | Fairman Jeff | VP, Research | Sell | S | 25.33 | 68 | 1,722 | 1,408 | 1.5 K to 1.4 K (-4.61 %) |
| Mar 02 2021 | PCVX | Vaxcyte, Inc. | Fairman Jeff | VP, Research | Sell | S | 24.34 | 1,372 | 33,394 | 1,476 | 2.8 K to 1.5 K (-48.17 %) |
| Mar 02 2021 | PCVX | Vaxcyte, Inc. | Fairman Jeff | VP, Research | Sell | S | 23.73 | 3,310 | 78,546 | 2,848 | 6.2 K to 2.8 K (-53.75 %) |
| Mar 02 2021 | PCVX | Vaxcyte, Inc. | Fairman Jeff | VP, Research | Buy | M | 0.04 | 4,750 | 190 | 6,158 | 1.4 K to 6.2 K (+337.36 %) |
| Jan 28 2021 | PCVX | Vaxcyte, Inc. | Fairman Jeff | VP, Research | Option Exercise | M | 0.04 | 4,750 | 190 | 16,759 | |
| Jan 28 2021 | PCVX | Vaxcyte, Inc. | Fairman Jeff | VP, Research | Sell | S | 25.94 | 425 | 11,025 | 1,408 | 1.8 K to 1.4 K (-23.19 %) |
| Jan 28 2021 | PCVX | Vaxcyte, Inc. | Fairman Jeff | VP, Research | Sell | S | 25.20 | 4,325 | 108,990 | 1,833 | 6.2 K to 1.8 K (-70.23 %) |
| Jan 28 2021 | PCVX | Vaxcyte, Inc. | Fairman Jeff | VP, Research | Buy | M | 0.04 | 4,750 | 190 | 6,158 | 1.4 K to 6.2 K (+337.36 %) |
| Dec 30 2020 | PCVX | Vaxcyte, Inc. | Fairman Jeff | VP, Research | Option Exercise | M | 1.79 | 740 | 1,325 | 91,629 | |
| Dec 30 2020 | PCVX | Vaxcyte, Inc. | Fairman Jeff | VP, Research | Buy | M | 1.79 | 740 | 1,325 | 1,408 | 668 to 1.4 K (+110.78 %) |
| Dec 30 2020 | PCVX | Vaxcyte, Inc. | Fairman Jeff | VP, Research | Option Exercise | M | 1.79 | 740 | 1,325 | 91,629 | |
| Dec 30 2020 | PCVX | Vaxcyte, Inc. | Fairman Jeff | VP, Research | Buy | M | 1.79 | 740 | 1,325 | 1,408 | 668 to 1.4 K (+110.78 %) |
Page: 1